Event Content

Innovative approaches to medicine distribution frequently fall short of reaching the people who need them the most, particularly in developing nations where acceptance is slowed by legislative, financial, and infrastructure constraints. Using India as a manufacturing powerhouse and a case study in unmet a...

ReciBioPharm introduces an advanced process analytical technology (PAT) platform for RNA therapeutics that leverages in-line PAT and machine learning to enable real-time monitoring, control, and optimization. PAT tools provide continuous data throughout the production process—from plasmid linearization to ...

Global pharmaceutical manufacturing is being redefined by a new era of trade friction, industrial policy, and strategic decoupling. As governments rethink supply chain security and impose new tariffs and incentives, capital is following a different path—away from traditional hubs and toward regionalized, p...

Wearable devices that monitor vital signs, physical activity, and other health metrics are now utilized by approximately one in three individuals for tracking personal health and wellness. Despite their evident advantages, the integration and widespread adoption of connected devices within the healthcare s...

As GLP-1 therapies gain traction in combating obesity nationwide, their success is transforming the pharmaceutical landscape.

Unlock the potential of Research & Development with strategic process optimization. Explore the challenges of implementing operational excellence in the dynamic R&D environment and learn how to develop a tailored roadmap that enhances efficiency, fosters innovation, and drives sustainable growth. • Cha...

During the past several decades, drug development sponsors have implemented a number of approaches to reduce operating inefficiencies focusing largely on within-function process improvements.  Recently, sponsors have turned their attention to reducing the inefficiencies between  functional collaborations....

Key discussion points: 1. Introduction of botanical prescription drugs, 2. Outline of a growing interest in evidence based natural products including stats from practitioners and patients, 3. Botanical prescription drug - clinical trial requirements, 4. Advancements in clinical trials in the research of co...

The presentation will delve into how the LOG Pharma Primary Packaging team have addressed the challenge of designing eco-friendly oxygen and moisture barrier bottles. It will highlight the complexities of developing sustainable primary packaging for pharmaceuticals that comply with environmental standard...

This presentation looks at the crucial role of syringe closure systems in the field of prefilled syringes and injection devices, offering scientific insights into container closure development. With extensive experience of legacy closure systems, our company explores the potential of integrating historical...

Do we understand the true reality of what someone who isn't a Healthcare Professional goes through when they open the packaging and prepare to use a medical device in an emergency? After decades of feeding into the design and development of these devices, I was unfortunately one of those people. If I hadn’...

The evolving landscape of the pharmaceutical industry, marked by significant breakthroughs in advanced treatments and relentless pressures for speed and innovation, has fundamentally transformed the role of Contract Development and Manufacturing Organizations (CDMOs). As the industry faces challenges from ...

A new drug substance and drug product production route using integrated continuous manufacturing has been developed for a Roche drug. This new manufacturing process successfully addresses supply chain constraints and patient needs, reducing the lead time from 15 months down to 50 hours. • Equivalent yi...

During pharmaceutical product development, Boehringer Ingelheim generates hundreds of thousands of documents, each containing valuable knowledge and problem-solving strategies. • The challenge is to make this knowledge accessible within the company to avoid redundant efforts. To address this, Boehrin...

Big Pharma reports that up to over 90% of their CO2 emissions are scope 3. This is not only a huge burden but also the most difficult part to influence for pharmaceutical industry. However, there are ways to manage and collaborate in the industry. Christophe Marie from Aptar Group will highlight how Aptar ...

Data analytics is playing an increasingly important role in helping companies achieve supply chain excellence. By collecting and analyzing data, companies can gain insights into their supply chains that can help them improve efficiency, reduce costs, and improve customer service • How Data analytics ca...

A holistic view of the environmental impact of drug delivery devices. Exploring the challenges, obstacles, and opportunities to decarbonize the value chain and embed circularity. A call to action for collaboration across all stakeholders

Numerous drug technologies are advancing into pre-clinical and early clinical phases to enable new therapies with improved health outcomes. Those new technologies carry potential challenges pertaining to their compatibility with the container materials and with environmental conditions such as temperature ...

Today’s medicine and therapeutics encompass fairly complex formulations. The device design needs to not only incorporate the challenging needs of the formulation but also address patient optimized administration and deliver consistent results. The success of the clinical outcome is dependent on the deliver...

The validation of healthcare products and sterile barrier packaging prior to placing on the market is of the upmost importance to the safety of end user and patient. This presentation will give an overview of supporting testing and provide guidance on conducting successful studies.

Sterile pharmaceutical production is expected to grow by over 50% in the next seven years, driven by new demand for recombinant antibodies and small molecules. Consequently, the fill/finish stage in pharmaceutical manufacturing is becoming a bottleneck in the pharmaceutical production . Health authorities ...

Though viral vectors are used extensively in cell and gene therapy, the challenges of manufacturing such complex biologics at industrial scale is still a limitation to its broader use.
Dr. Ayuso will speak about how upstream and downstream process optimization using design of experiments (DOE), a p...

Plastic solutions in healthcare are vital. Though carbon emissions and wastefulness are inherent in today’s linear economy, changes are needed across the pharma and healthcare industry. To manage this in a safe way, strong value-chain collaboration is needed.
Key talking points include:
A...

mRNA vaccines helped us through the COVID-19 pandemic — but they could also help defend against many other infectious diseases. Join Moderna to understand how mRNA can play a key role in future therapies.
• Learnings from the COVID-19 vaccine and translating mRNA technology to other therapy areas...

Outlining collaborative and communication strategies that can help enhance an outsourcing partnership The importance of information sharing between client and vendor for effective situation response Case study showcase of a successfully implemented partnership strategy

Pharmaceutical and other healthcare innovations have extended and improved countless lives in recent decades. Today, advanced manufacturing technologies such as pharmaceutical continuous manufacturing are gaining increasing interest for their potential to serve as one more way to improve global health by b...

With constraints on clinical supplies due to high demand, the industry is scrambling to find a solution. Join our focused panel, where our experts will offer insights and tips for designing a supply chain to help meet current supply needs: • Investing in smarter processes and forecasting technology to ...

Where QBD was the orchestral sheet music that determined how drug product development has been harmonized over the last 15 or so years, contemporary patient-centric risk-based approaches to drug development are the pop evolution. The music is still beautiful when produced well - but the focus is no longer...

Managing the biopharma supply chain is a highly complex undertaking that is becoming ever more so as the number of new products rises and new process technologies are introduced. Moving with ease from one step to the next (R&D, production, distribution) while adhering to regulations and meeting customer de...

Transitioning drugs from IV to subcutaneous (SC) delivery brings new requirements and impacts program considerations for combination product development. In this session, we identify trade-offs that pharma weighs to de-risk combination product development programs involving large volume subcutaneous (LVSC...

We at Körber believe the pharmaceutical industry will ultimately dispense of plastic packaging within a few years. Our Rondo Solutions are pioneering when it comes to sustainability. Today pharmaceutical packaging expects to be innovative, compact, safe, and environmentally friendly. That’s because opin...

This session will give insights on the trends our sector is facing: decarbonization and circular economy. It will also provide an overview on the work done at industry level. And finally, you will be able to learn more on what Saint-Gobain Life Sciences is willing to offer to supply single-use technologies...

Packaging is an integral part of the design for pharmaceutical products and medical devices. Not only does one need to take into account the look, feel, and protective qualities of the packaging but design must be considered when determining the sterilization technology. Determining the sterilization techn...

Indena’s view and technology expansion to support partners’ developments.

Supported by more than 100 year experience, Indena has been involved ever since in the CDMO activities on behalf of its partners, even before CDMO was so named. Starting from the extraction, chromatographic purification an...

Advanced therapy clinical trials are growing, with a record number of therapies being approved in 2021. This increase in approvals has led many to predict that the commercialization of advanced therapies is not far away

It offers the potential for fantastic breakthroughs for patients. But it’s v...

This short session answers the most pressuring strategic questions with regards to sustainability: Why does it matter? Where to focus? How is it measured? What is the current industry status? How to improve?

Did you enjoy this session? If so, you might like to visit our Connect to Frankfurt plat...

CPHI is back in Frankfurt, an important hub for the German pharmaceutical community. This session will explore the German market and look at the abundance of innovation emerging from one of Europe's biggest pharma hubs.
This session will touch upon: • Access to Innovative Medicines and Launch Pe...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Dr. Robert Lindner, Global Product Manager RTU Vials, SCHOTT AG will discuss how sterile integrity is indispensable in aseptic fill-and-finish operations. Pharmaceutical companies pay highest attention to producing high quality d...

This session will explore the value of considering the user experience for patients and how best to build it. What does the consumer sector have to show drug delivery about creating compelling experiences and reassuring users? How can packaging guide users during their journey, from onboarding to succe...

In this webinar, originally broadcast as part of the Pharmapack Europe show, speaker Aurelio Areas, Engagement Manager, IQVIA will give us a look at the global outlook of the pharma industry as it emerges from the pandemic with a focus on drug delivery trends. This session analyses current dynamics in drug...

In this webinar, originally part of Pharmapack Europe 2022, Thomas Watts, Engineering Consultant, Team Consulting discusses tackling the challenges of cloud connectivity. The electronic Product Information initiative for Medicines (ePI) aim to ease the accessibility on product information to everyone with...

As global governments and businesses increasingly make bold claims and commitments to tackle the climate emergency, investors are starting to take note by using the ESG framework to move beyond environmental concerns and focus on a company's impact on all the different ecosystems it operates in. The ris...

In this webinar is originally broadcast as part of CPHI North America, with speakers Robert Bloder, Chief Business Officer, Ascendia Pharma, Chris Senanayake, CEO & CSO, TCG GreenChem, Inc. and John Pennett, Partner-in-Charge of the National Technology and Life Sciences Group, EisnerAmper. The thread line:...

This presentation will focus on: The complexities of bioprocessing and manufacturing of biologics to provide a roadmap for development of effective Efficient and scalable processes and platforms that can be adopted successfully to provide patients wide access to cell and gene therapies. This session...

In this webinar, originally broadcast as part of CPHI NA, Michael Sassano, CEO and Chairman, Somai Pharmaceuticals discusses: • Global Pharmaceutical Cannabis market and the history of recent growth • Current trends in the Medical Cannabis market versus the Canadian and American experience • Herbal M...